Didier Jutras-Aswad

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 56

Top Topics

Randomized Controlled Trial

Systematic Review

Hepatitis C Virus Infection

Top Venues

Canadian journal of psychiatry. Revue canadienne de psychiatrie

Addiction (Abingdon, England)

Drug and alcohol review

Journal of medical Internet research

This page only lists publications with an associated author ORCID identifier.

Publications

José Côté, Gabrielle Chicoine, Billy Vinette, Patricia Auger, Geneviève Rouleau, Guillaume Fontaine, Didier Jutras-Aswad
Digital Interventions for Recreational Cannabis Use Among Young Adults: Systematic Review, Meta-Analysis, and Behavior Change Technique Analysis of Randomized Controlled Studies. Journal of medical Internet research 26 (2024)
José Côté, Gabrielle Chicoine, Billy Vinette, Patricia Auger, Geneviève Rouleau, Guillaume Fontaine, Didier Jutras-Aswad
Digital Interventions for Recreational Cannabis Use Among Young Adults: Systematic Review, Meta-Analysis, and Behavior Change Technique Analysis of Randomized Controlled Studies. Journal of medical Internet research 26 (2024)
Stephanie Coronado-Montoya, Amal Abdel-Baki, David Crockford, José Côté, Simon Dubreucq, Alina Dyachenko, Benedikt Fischer, Tania Lecomte, Sophie L'Heureux, Clairélaine Ouellet-Plamondon, Marc-André Roy, Philip Tibbo, Marie Villeneuve, Didier Jutras-Aswad
Preferences of Young Adults With Psychosis for Cannabis-Focused Harm Reduction Interventions: A Cross-Sectional Study: Préférences des jeunes adultes souffrant de psychose pour les interventions de réduction des méfaits axées sur le cannabis : une étude transversale. Canadian journal of psychiatry. Revue canadienne de psychiatrie 69 (7) (2024)
Laurent Elkrief, Heidar Sharafi, Hamzah Bakouni, Christina McAnulty, Gabriel Bastien, Simon Dubreucq, Nicolas Garel, Annie Trépanier, Daniela Ziegler, Didier Jutras-Aswad
Efficacy and Safety of Modafinil for Treatment of Amphetamine-Type Stimulant Use Disorder: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials: Efficacité et innocuité du modafinil pour le traitement des troubles liés à l'usage de stimulants de type amphétamine : revue systématique et méta-analyse d'essais randomisés contrôlés par placebo. Canadian journal of psychiatry. Revue canadienne de psychiatrie (2024)
José Côté, Gabrielle Chicoine, Billy Vinette, Patricia Auger, Geneviève Rouleau, Guillaume Fontaine, Didier Jutras-Aswad
Digital Interventions for Recreational Cannabis Use Among Young Adults: Systematic Review, Meta-Analysis, and Behavior Change Technique Analysis of Randomized Controlled Studies. Journal of medical Internet research 26 (2024)
Hannah Crepeault, Lianping Ti, Paxton Bach, Evan Wood, Didier Jutras-Aswad, Bernard Le Foll, Ron Lim, Maria Eugenia Sociás
Opioid agonist treatment outcomes among individuals with a history of nonfatal overdose: Findings from a pragmatic, pan-Canadian, randomized control trial. The American journal on addictions (2024)
Stephanie Coronado-Montoya, Amal Abdel-Baki, David Crockford, José Côté, Simon Dubreucq, Alina Dyachenko, Benedikt Fischer, Tania Lecomte, Sophie L'Heureux, Clairélaine Ouellet-Plamondon, Marc-André Roy, Philip Tibbo, Marie Villeneuve, Didier Jutras-Aswad
Preferences of Young Adults With Psychosis for Cannabis-Focused Harm Reduction Interventions: A Cross-Sectional Study: Préférences des jeunes adultes souffrant de psychose pour les interventions de réduction des méfaits axées sur le cannabis : une étude transversale. Canadian journal of psychiatry. Revue canadienne de psychiatrie 69 (7) (2024)
Stephanie Coronado-Montoya, Amal Abdel-Baki, David Crockford, José Côté, Simon Dubreucq, Alina Dyachenko, Benedikt Fischer, Tania Lecomte, Sophie L'Heureux, Clairélaine Ouellet-Plamondon, Marc-André Roy, Philip Tibbo, Marie Villeneuve, Didier Jutras-Aswad
Preferences of Young Adults With Psychosis for Cannabis-Focused Harm Reduction Interventions: A Cross-Sectional Study: Préférences des jeunes adultes souffrant de psychose pour les interventions de réduction des méfaits axées sur le cannabis : une étude transversale. Canadian journal of psychiatry. Revue canadienne de psychiatrie 69 (7) (2024)
Gabriel Bastien, Anita Abboud, Christina McAnulty, Laurent Elkrief, Omar Ledjiar, Maria Eugenia Sociás, Bernard Le Foll, Anees Bahji, Suzanne Brissette, Stéphanie Marsan, Didier Jutras-Aswad
Impact of Depressive Symptom Severity on Buprenorphine/Naloxone and Methadone Outcomes in People With Prescription-Type Opioid Use Disorder: Results From a Pragmatic Randomized Controlled Trial. Journal of dual diagnosis 20 (3) (2024)
Heidar Sharafi, Didier Jutras-Aswad
Response to Hall et al.: Prescription psychostimulants for amphetamine-type stimulant use disorder - acknowledging challenges but not giving up on its potential cost-effectiveness. Addiction (Abingdon, England) 119 (4) (2024)
Jenna Langlois, Nadia Fairbairn, Didier Jutras-Aswad, Bernard Le Foll, Ron Lim, Maria Eugenia Sociás
Characterising methamphetamine/amphetamine use among opioid agonist therapy-seeking adults with prescription-type opioid use disorder in Canada. Drug and alcohol review (2024)
Stephanie Coronado-Montoya, Amal Abdel-Baki, David Crockford, José Côté, Simon Dubreucq, Alina Dyachenko, Benedikt Fischer, Tania Lecomte, Sophie L'Heureux, Clairélaine Ouellet-Plamondon, Marc-André Roy, Philip Tibbo, Marie Villeneuve, Didier Jutras-Aswad
Preferences of Young Adults With Psychosis for Cannabis-Focused Harm Reduction Interventions: A Cross-Sectional Study: Préférences des jeunes adultes souffrant de psychose pour les interventions de réduction des méfaits axées sur le cannabis : une étude transversale. Canadian journal of psychiatry. Revue canadienne de psychiatrie (2024)
Gabriel Bastien, Anita Abboud, Christina McAnulty, Laurent Elkrief, Omar Ledjiar, Maria Eugenia Sociás, Bernard Le Foll, Anees Bahji, Suzanne Brissette, Stéphanie Marsan, Didier Jutras-Aswad
Impact of Depressive Symptom Severity on Buprenorphine/Naloxone and Methadone Outcomes in People With Prescription-Type Opioid Use Disorder: Results From a Pragmatic Randomized Controlled Trial. Journal of dual diagnosis (2024)
Heidar Sharafi, Didier Jutras-Aswad
Response to Hall et al.: Prescription psychostimulants for amphetamine-type stimulant use disorder - acknowledging challenges but not giving up on its potential cost-effectiveness. Addiction (Abingdon, England) 119 (4) (2024)
José Côté, Gabrielle Chicoine, Billy Vinette, Patricia Auger, Geneviève Rouleau, Guillaume Fontaine, Didier Jutras-Aswad
Digital Interventions for Recreational Cannabis Use Among Young Adults: Systematic Review, Meta-Analysis, and Behavior Change Technique Analysis of Randomized Controlled Studies. Journal of medical Internet research 26 (2024)
Jenna Langlois, Nadia Fairbairn, Didier Jutras-Aswad, Bernard Le Foll, Ron Lim, Maria Eugenia Sociás
Impact of baseline methamphetamine/amphetamine use on discontinuation of methadone and buprenorphine/naloxone among people with prescription-type opioid use disorder in Canada. The American journal on addictions (2024)
Stephanie Coronado-Montoya, Amal Abdel-Baki, David Crockford, José Côté, Simon Dubreucq, Alina Dyachenko, Benedikt Fischer, Tania Lecomte, Sophie L'Heureux, Clairélaine Ouellet-Plamondon, Marc-André Roy, Philip Tibbo, Marie Villeneuve, Didier Jutras-Aswad
Preferences of Young Adults With Psychosis for Cannabis-Focused Harm Reduction Interventions: A Cross-Sectional Study: Préférences des jeunes adultes souffrant de psychose pour les interventions de réduction des méfaits axées sur le cannabis : une étude transversale. Canadian journal of psychiatry. Revue canadienne de psychiatrie 69 (7) (2024)
Heidar Sharafi, Didier Jutras-Aswad
Response to Hall et al.: Prescription psychostimulants for amphetamine-type stimulant use disorder - acknowledging challenges but not giving up on its potential cost-effectiveness. Addiction (Abingdon, England) 119 (4) (2024)
Heidar Sharafi, Didier Jutras-Aswad
Response to Hall et al.: Prescription psychostimulants for amphetamine-type stimulant use disorder - acknowledging challenges but not giving up on its potential cost-effectiveness. Addiction (Abingdon, England) (2024)
Iuliia Makarenko, Nanor Minoyan, Stine Bordier Høj, Sasha Udhesister, Valérie Martel-Laferrière, Didier Jutras-Aswad, Sarah Larney, Julie Bruneau
Determinants of psychological distress during the COVID-19 pandemic among people who use drugs in Montreal, Canada. Drug and alcohol review (2024)
José Côté, Gabrielle Chicoine, Billy Vinette, Patricia Auger, Geneviève Rouleau, Guillaume Fontaine, Didier Jutras-Aswad
Digital Interventions for Recreational Cannabis Use Among Young Adults: Systematic Review, Meta-Analysis, and Behavior Change Technique Analysis of Randomized Controlled Studies. Journal of medical Internet research 26 (2024)
Hamzah Bakouni, Christina McAnulty, Ovidiu Tatar, M Eugenia Socias, Bernard Le Foll, Ron Lim, Keith Ahamad, Didier Jutras-Aswad, null null
Associations of methadone and buprenorphine-naloxone doses with unregulated opioid use, treatment retention, and adverse events in prescription-type opioid use disorders: Exploratory analyses of the OPTIMA study. The American journal on addictions (2023)
Benedikt Fischer, Tessa Robinson, Didier Jutras-Aswad
Three noteworthy idiosyncrasies related to Canada's opioid-death crisis, and implications for public health-oriented interventions. Drug and alcohol review 43 (2) (2023)
Stephanie Coronado-Montoya, Amal Abdel-Baki, José Côté, David Crockford, Simon Dubreucq, Benedikt Fischer, Pamela Lachance-Touchette, Tania Lecomte, Sophie L'Heureux, Clairélaine Ouellet-Plamondon, Marc-André Roy, Ovidiu Tatar, Philip G Tibbo, Marie Villeneuve, Anne Wittevrongel, Didier Jutras-Aswad
Evaluation of a Cannabis Harm Reduction Intervention for People With First-Episode Psychosis: Protocol for a Pilot Multicentric Randomized Trial. JMIR research protocols 12 (2023)
Benedikt Fischer, Tessa Robinson, Didier Jutras-Aswad
Three noteworthy idiosyncrasies related to Canada's opioid-death crisis, and implications for public health-oriented interventions. Drug and alcohol review (2023)
Benedikt Fischer, Tessa Robinson, Didier Jutras-Aswad
Three noteworthy idiosyncrasies related to Canada's opioid-death crisis, and implications for public health-oriented interventions. Drug and alcohol review 43 (2) (2023)
Stephanie Coronado-Montoya, Amal Abdel-Baki, José Côté, David Crockford, Simon Dubreucq, Benedikt Fischer, Pamela Lachance-Touchette, Tania Lecomte, Sophie L'Heureux, Clairélaine Ouellet-Plamondon, Marc-André Roy, Ovidiu Tatar, Philip G Tibbo, Marie Villeneuve, Anne Wittevrongel, Didier Jutras-Aswad
Evaluation of a Cannabis Harm Reduction Intervention for People With First-Episode Psychosis: Protocol for a Pilot Multicentric Randomized Trial. JMIR research protocols 12 (2023)
Benedikt Fischer, Tessa Robinson, Didier Jutras-Aswad
Three noteworthy idiosyncrasies related to Canada's opioid-death crisis, and implications for public health-oriented interventions. Drug and alcohol review (2023)
Benedikt Fischer, Tessa Robinson, Didier Jutras-Aswad
Three noteworthy idiosyncrasies related to Canada's opioid-death crisis, and implications for public health-oriented interventions. Drug and alcohol review 43 (2) (2023)
Léonie Archambault, Karine Bertrand, Didier Jutras-Aswad, Eva Monson, El Hadj Touré, Michel Perreault
People with opioid use disorders: A taxonomy of treatment entrants to support the development of a profile-based approach to care. Drug and alcohol review (2023)
Heidar Sharafi, Hamzah Bakouni, Christina McAnulty, Sarah Drouin, Stephanie Coronado-Montoya, Arash Bahremand, Paxton Bach, Nadine Ezard, Bernard Le Foll, Christian G Schütz, Krista J Siefried, Vitor Soares Tardelli, Daniela Ziegler, Didier Jutras-Aswad
Prescription psychostimulants for the treatment of amphetamine-type stimulant use disorder: A systematic review and meta-analysis of randomized placebo-controlled trials. Addiction (Abingdon, England) (2023)
Benedikt Fischer, Wayne Denis Hall, Thiago Marques Fidalgo, Eva Hoch, Bernard Le Foll, María Elena Medina Mora, Jens Reimer, Philip G Tibbo, Didier Jutras-Aswad
Recommendations for Reducing the Risk of Cannabis Use-Related Adverse Psychosis Outcomes: A Public Mental Health-Oriented Evidence Review. Journal of dual diagnosis (2023)
Stephanie Coronado-Montoya, Amal Abdel-Baki, José Côté, David Crockford, Simon Dubreucq, Benedikt Fischer, Pamela Lachance-Touchette, Tania Lecomte, Sophie L'Heureux, Clairélaine Ouellet-Plamondon, Marc-André Roy, Ovidiu Tatar, Philip G Tibbo, Marie Villeneuve, Anne Wittevrongel, Didier Jutras-Aswad
Evaluation of a Cannabis Harm Reduction Intervention for People With First-Episode Psychosis: Protocol for a Pilot Multicentric Randomized Trial. JMIR research protocols 12 (2023)
Stephanie Coronado-Montoya, Amal Abdel-Baki, José Côté, David Crockford, Simon Dubreucq, Benedikt Fischer, Pamela Lachance-Touchette, Tania Lecomte, Sophie L'Heureux, Clairélaine Ouellet-Plamondon, Marc-André Roy, Ovidiu Tatar, Philip G Tibbo, Marie Villeneuve, Anne Wittevrongel, Didier Jutras-Aswad
Evaluation of a Cannabis Harm Reduction Intervention for People With First-Episode Psychosis: Protocol for a Pilot Multicentric Randomized Trial. JMIR research protocols 12 (2023)
Benedikt Fischer, Tessa Robinson, Didier Jutras-Aswad
Three noteworthy idiosyncrasies related to Canada's opioid-death crisis, and implications for public health-oriented interventions. Drug and alcohol review 43 (2) (2023)
David G T Whitehurst, Cassandra Mah, Emanuel Krebs, Benjamin Enns, Maria Eugenia Sociás, Didier Jutras-Aswad, Bernard Le Foll, Bohdan Nosyk, null null
Sensitivity to change of generic preference-based instruments (EQ-5D-3L, EQ-5D-5L, and HUI3) in the context of treatment for people with prescription-type opioid use disorder in Canada. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation (2023)
Nicolas Garel, Kyle T Greenway, Lê-Anh L Dinh-Williams, Julien Thibault-Levesque, Didier Jutras-Aswad, Gustavo Turecki, Soham Rej, Stephane Richard-Devantoy
Intravenous ketamine for benzodiazepine deprescription and withdrawal management in treatment-resistant depression: a preliminary report. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology (2023)
Hamzah Bakouni, Heidar Sharafi, Sarah Drouin, Raphaelle Fortin, Stéphanie Marsan, Suzanne Brissette, Maria Eugenia Socias, Bernard Le Foll, Ron Lim, Didier Jutras-Aswad
Associations Between Buprenorphine\Naloxone and Methadone Treatment and non-Opioid Substance Use in Prescription-Type Opioid Use Disorder: Secondary Analyses From the OPTIMA Study. Canadian journal of psychiatry. Revue canadienne de psychiatrie (2023)
Imane Guemghar, Paula Pires de Oliveira Padilha, Amal Abdel-Baki, Didier Jutras-Aswad, Jesseca Paquette, Marie-Pascale Pomey
Social Robot Interventions in Mental Health Care and Their Outcomes, Barriers, and Facilitators: Scoping Review. JMIR mental health 9 (4) (2022)
Ovidiu Tatar, Amal Abdel-Baki, Anne Wittevrongel, Tania Lecomte, Jan Copeland, Pamela Lachance-Touchette, Stephanie Coronado-Montoya, José Côté, David Crockford, Simon Dubreucq, Sophie L'Heureux, Clairélaine Ouellet-Plamondon, Marc-André Roy, Philip G Tibbo, Marie Villeneuve, Didier Jutras-Aswad
Reducing Cannabis Use in Young Adults With Psychosis Using iCanChange, a Mobile Health App: Protocol for a Pilot Randomized Controlled Trial (ReCAP-iCC). JMIR research protocols 11 (11) (2022)
Gabrielle Chicoine, José Côté, Jacinthe Pepin, Alina Dyachenko, Guillaume Fontaine, Didier Jutras-Aswad
Improving the self-efficacy, knowledge, and attitude of nurses regarding concurrent disorder care: Results from a prospective cohort study of an interprofessional, videoconference-based programme using the ECHO model. International journal of mental health nursing (2022)
Gabrielle Chicoine, José Côté, Jacinthe Pepin, Louise Boyer, Geneviève Rouleau, Didier Jutras-Aswad
Experiences and perceptions of nurses participating in an interprofessional, videoconference-based educational programme on concurrent mental health and substance use disorders: a qualitative study. BMC nursing 21 (1) (2022)
Tessa Robinson, Muhammad Usman Ali, Bethany Easterbrook, Wayne Denis Hall, Didier Jutras-Aswad, Benedikt Fischer
Risk-thresholds for the association between frequency of cannabis use and the development of psychosis: a systematic review and meta-analysis. Psychological medicine (2022)
Gabriel Bastien, Christina McAnulty, Omar Ledjiar, M Eugenia Socias, Bernard Le Foll, Ron Lim, Ahmed N Hassan, Suzanne Brissette, Stéphanie Marsan, Annie Talbot, Didier Jutras-Aswad, null null
Effects of Buprenorphine/Naloxone and Methadone on Depressive Symptoms in People with Prescription Opioid Use Disorder: A Pragmatic Randomised Controlled Trial. Canadian journal of psychiatry. Revue canadienne de psychiatrie (2022)
Sarah Drouin, Élie Rizkallah, Florence Conus, Sarah Larney, Navdeep Kaur, Codjo Djignefa Djade, Didier Jutras-Aswad
Association Between Markers of Vulnerability for Cannabis-Related Harms and Source of Supply: Secondary Analysis of a Representative Population Survey. Canadian journal of psychiatry. Revue canadienne de psychiatrie (2022)
Maria Eugenia Sociás, Evan Wood, Bernard Le Foll, Ron Lim, Jin Cheol Choi, Wing Yin Mok, Julie Bruneau, Jürgen Rehm, T Cameron Wild, Nikki Bozinoff, Ahmed N Hassan, Didier Jutras-Aswad, null null
Impact of fentanyl use on initiation and discontinuation of methadone and buprenorphine/naloxone among people with prescription-type opioid use disorder: secondary analysis of a Canadian treatment trial. Addiction (Abingdon, England) 117 (10) (2022)
Violaine Mongeau-Pérusse, Suzanne Brissette, Julie Bruneau, Patricia Conrod, Simon Dubreucq, Guillaume Gazil, Emmanuel Stip, Didier Jutras-Aswad
Cannabidiol as a treatment for craving and relapse in individuals with cocaine use disorder: a randomized placebo-controlled trial. Addiction (Abingdon, England) 116 (9) (2021)
Violaine Mongeau-Pérusse, Elie Rizkallah, Julie Bruneau, Denis Chênevert, Loick Menvielle, Didier Jutras-Aswad
Changes in Alcohol Habits Among Workers During the Confinement of COVID-19: Results of a Canadian Cross-Sectional Survey. Substance abuse : research and treatment 15 (2021)
Ovidiu Tatar, Amal Abdel-Baki, Christophe Tra, Violaine Mongeau-Pérusse, Nelson Arruda, Navdeep Kaur, Vivianne Landry, Stephanie Coronado-Montoya, Didier Jutras-Aswad
Technology-Based Psychological Interventions for Young Adults With Early Psychosis and Cannabis Use Disorder: Qualitative Study of Patient and Clinician Perspectives. JMIR formative research 5 (4) (2021)
Dimitri Daldegan-Bueno, Lucas Oliveira Maia, Michelle Glass, Didier Jutras-Aswad, Benedikt Fischer
Co-exposure of cannabinoids with amphetamines and biological, behavioural and health outcomes: a scoping review of animal and human studies. Psychopharmacology (2021)
Florence Morissette, Violaine Mongeau-Pérusse, Elie Rizkallah, Paméla Thébault, Stéphanie Lepage, Suzanne Brissette, Julie Bruneau, Simon Dubreucq, Emmanuel Stip, Jean-François Cailhier, Didier Jutras-Aswad
Exploring cannabidiol effects on inflammatory markers in individuals with cocaine use disorder: a randomized controlled trial. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 46 (12) (2021)
Violaine Mongeau-Pérusse, Didier Jutras-Aswad
Challenging CBD protective effect against THC-related outcomes: a call for robust clinical trials. Addiction (Abingdon, England) 116 (1) (2020)
Maykel Farag Ghabrash, Arash Bahremand, Martine Veilleux, Geneviève Blais-Normandin, Gabrielle Chicoine, Catherine Sutra-Cole, Navdeep Kaur, Daniela Ziegler, Simon Dubreucq, Louis-Christophe Juteau, Laurent Lestage, Didier Jutras-Aswad
Depression and Outcomes of Methadone and Buprenorphine Treatment Among People with Opioid Use Disorders: A Literature Review. Journal of dual diagnosis 16 (2) (2020)
Stephanie Coronado-Montoya, Florence Morissette, Amal Abdel-Baki, Benedikt Fischer, José Côté, Clairélaine Ouellet-Plamondon, Laurence Tremblay, Didier Jutras-Aswad
Preventive interventions targeting cannabis use and related harms in people with psychosis: A systematic review. Early intervention in psychiatry 15 (6) (2020)
Brendan P Jacka, Élise Roy, Stine Bordier Høj, Nanor Minoyan, Andreea Adelina Artenie, Geng Zang, Didier Jutras-Aswad, Julie Bruneau
Sexual behaviour as a risk factor for hepatitis C virus infection among people who inject drugs in Montreal, Canada. Journal of viral hepatitis 26 (12) (2019)
Emmanuel Fortier, Andreea Adelina Artenie, Geng Zang, Didier Jutras-Aswad, Élise Roy, Jason Grebely, Julie Bruneau
Short and sporadic injecting cessation episodes as predictors of incident hepatitis C virus infection: findings from a cohort study of people who inject drugs in Montréal, Canada. Addiction (Abingdon, England) 114 (8) (2019)
Jean-Marie Bamvita, Elise Roy, Geng Zang, Didier Jutras-Aswad, Andreea Adelina Artenie, Annie Levesque, Julie Bruneau
Portraying persons who inject drugs recently infected with hepatitis C accessing antiviral treatment: a cluster analysis. Hepatitis research and treatment 2014 (2014)